Back to Market Feed

RYBELSUS 14 MG TABLET

Oral Semaglutide
$33.1671per EA

Strength

14 mg/1

Manufacturer

Novo Nordisk

NDC

00169431430

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

SEMAGLUTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA213051

On Market Since

9/20/2019

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+3.3%

3Y

+10.6%

5Y

N/A

All

+16.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SOLIQUA 100 UNIT-33 MCG/ML PEN
Brand
00024576105•Sanofi-Aventis U.S. LLC
$57.0731
per ML
XULTOPHY 100 UNIT-3.6 MG/ML PEN
Brand
00169291115•Novo Nordisk
$85.8558
per ML
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1538
per ML
VICTOZA 2-PAK 18 MG/3 ML PEN
Brand
00169406012•Novo Nordisk
$87.7373
per ML
VICTOZA 3-PAK 18 MG/3 ML PEN
Brand
00169406013•Novo Nordisk
$87.8351
per ML
OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN
Brand
00169477212•Novo Nordisk
$331.9569
per ML
OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN
Brand
00169413013•Novo Nordisk
$331.9930
per ML
OZEMPIC 0.25-0.5 MG/DOSE (2 MG/3 ML) PEN
Brand
00169418113•Novo Nordisk
$332.0230
per ML
BYETTA 10 MCG DOSE PEN INJ
Brand
00310652401•AstraZeneca Pharmaceuticals LP
$340.1014
per ML
WEGOVY 2.4 MG/0.75 ML PEN
Brand
00169452414•Novo Nordisk
$435.4326
per ML